4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-19-017420
Chief Executive Officer sold 20,000 shares at $46.00 ($920,000)
- Chief Executive Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2019-06-17 | Option exercise | +20,000 | $1.81 | $36,200 | 185,801 | D |
| Kulkarni Samarth Chief Executive Officer | 2019-06-17 | Sale | −20,000 | $46.00 | $920,000 | 165,801 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2019-06-17 | Option exercise · Stock Option (Right to Buy) | −20,000 | 203,058 | D | ||
| Open-market sales · 20,000 sh · avg $46.00 · $920,000 | |||||||
Loading xslF345X03/doc4.xml…